Using molecular tests to guide radiation after uterine cancer surgery
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether using genetic information (molecular classification) along with standard factors helps decide if you should have radiation after surgery for early-stage uterine cancer. It aims to improve treatment and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 to 75.
- You must have been diagnosed with endometrioid adenocarcinoma, a common type of uterine cancer.
- You need to be generally healthy and able to manage your daily activities.
- You must have had surgery to remove your uterus and ovaries.
- Your cancer must be early-stage (stage I or II) and meet certain risk factors like tumor grade, age, or lymph node involvement.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether radiation therapy after surgery is safe and effective for early-stage endometrial cancer. It is designed for patients with certain molecular subtypes and who have not had chemotherapy.
This trial compares different “fractionation” schedules (how often and how many treatments) of vaginal brachytherapy radiation given after surgery for certain early-stage endometrial cancer. It may help find a plan that works well while aiming to control side effects.
This trial tests a precise type of radiation (stereotactic radiotherapy) given after surgery for endometrial cancer. It aims to improve treatment while reducing side effects.
This study compares different ways of giving radiation and chemotherapy after surgery for stage III endometrial (uterine) cancer. It aims to find which approach works best to reduce cancer risk and improve outcomes.
This trial tests a shorter, focused radiation treatment to the pelvis after surgery for cervical or uterine cancer. It aims to reduce the chance of cancer coming back in patients whose doctors recommend additional radiation therapy after their surgery.
This trial tests a new way of giving radiation therapy after surgery for endometrial cancer. It uses MRI scans to guide the radiation, which may help target the treatment more precisely and reduce side effects.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.